Charles River Laboratories
625 hedge funds and large institutions have $10.8B invested in Charles River Laboratories in 2022 Q4 according to their latest regulatory filings, with 106 funds opening new positions, 224 increasing their positions, 218 reducing their positions, and 54 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
1.21% less ownership
Funds ownership: 98.94% → 97.73% (-1.2%)
10% less funds holding in top 10
Funds holding in top 10: 10 → 9 (-1)
54% less call options, than puts
Call options by funds: $20M | Put options by funds: $43M
Holders
625
Holding in Top 10
9
Calls
$20M
Puts
$43M
Top Buyers
| 1 | +$95.4M | |
| 2 | +$69.5M | |
| 3 | +$65.9M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$65.4M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$58M |
Top Sellers
| 1 | -$98.4M | |
| 2 | -$98.4M | |
| 3 | -$76.5M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$65.6M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$53.2M |